Category: 8. Health

  • New brain scan tool predicts aging speed and dementia risk

    New brain scan tool predicts aging speed and dementia risk

    Any high school reunion is a sharp reminder that some people age more gracefully than others. Some enter their older years still physically spry and mentally sharp. Others start feeling frail or forgetful much earlier in life than expected.

    The way we age as we get older is quite distinct from how many times we’ve traveled around the sun.”


    Ahmad Hariri, professor of psychology and neuroscience at Duke University

    Now, scientists at Duke, Harvard and the University of Otago in New Zealand have developed a freely available tool that can tell how fast someone is aging, and while they’re still reasonably healthy — by looking at a snapshot of their brain.

    From a single MRI brain scan, the tool can estimate your risk in midlife for chronic diseases that typically emerge decades later. That information could help motivate lifestyle and dietary changes that improve health.

    In older people, the tool can predict whether someone will develop dementia or other age-related diseases years before symptoms appear, when they might have a better shot at slowing the course of disease.

    “What’s really cool about this is that we’ve captured how fast people are aging using data collected in midlife,” Hariri said. “And it’s helping us predict diagnosis of dementia among people who are much older.”

    The results were published July 1 in the journal Nature Aging.

    Finding ways to slow age-related decline is key to helping people live healthier, longer lives. But first “we need to figure out how we can monitor aging in an accurate way,” Hariri said.

    Several algorithms have been developed to measure how well a person is aging. But most of these “aging clocks” rely on data collected from people of different ages at a single point in time, rather than following the same individuals as they grow older, Hariri said.

    “Things that look like faster aging may simply be because of differences in exposure” to things such as leaded gasoline or cigarette smoke that are specific to their generation, Hariri said.

    The challenge, he added, is to come up with a measure of how fast the process is unfolding that isn’t confounded by environmental or historical factors unrelated to aging.

    To do that, the researchers drew on data gathered from some 1,037 people who have been studied since birth as part of the Dunedin Study, named after the New Zealand city where they were born between 1972 and 1973.

    Every few years, Dunedin Study researchers looked for changes in the participants’ blood pressure, body mass index, glucose and cholesterol levels, lung and kidney function and other measures — even gum recession and tooth decay.

    They used the overall pattern of change across these health markers over nearly 20 years to generate a score for how fast each person was aging.

    The new tool, named DunedinPACNI, was trained to estimate this rate of aging score using only information from a single brain MRI scan that was collected from 860 Dunedin Study participants when they were 45 years old.

    Next the researchers used it to analyze brain scans in other datasets from people in the U.K., the U.S., Canada and Latin America.

    Faster aging and higher dementia risk

    Across data sets, they found that people who were aging faster by this measure performed worse on cognitive tests and showed faster shrinkage in the hippocampus, a brain region crucial for memory.

    More soberingly, they were also more likely to experience cognitive decline in later years.

    In one analysis, the researchers examined brain scans from 624 individuals ranging in age from 52 to 89 from a North American study of risk for Alzheimer’s disease.

    Those who the tool deemed to be aging the fastest when they joined the study were 60% more likely to develop dementia in the years that followed. They also started to have memory and thinking problems sooner than those who were aging slower.

    When the team first saw the results, “our jaws just dropped to the floor,” Hariri said.

    Links between body and brain

    The researchers also found that people whose DunedinPACNI scores indicated they were aging faster were more likely to suffer declining health overall, not just in their brain function.

    People with faster aging scores were more frail and more likely to experience age-related health problems such as heart attacks, lung disease or strokes.

    The fastest agers were 18% more likely to be diagnosed with a chronic disease within the next several years compared with people with average aging rates.

    Even more alarming, they were also 40% more likely to die within that timeframe than those who were aging more slowly, the researchers found.

    “The link between aging of the brain and body are pretty compelling,” Hariri said.

    The correlations between aging speed and dementia were just as strong in other demographic and socioeconomic groups than the ones the model was trained on, including a sample of people from Latin America, as well as United Kingdom participants who were low-income or non-White.

    “It seems to be capturing something that is reflected in all brains,” Hariri said.

    The work is important because people worldwide are living longer. In the coming decades, the number of people over age 65 is expected to double, reaching nearly one fourth of the world’s population by 2050.

    “But because we live longer lives, more people are unfortunately going to experience chronic age-related diseases, including dementia,” Hariri said.

    Dementia’s economic burden is already huge. Research suggests that the global cost of Alzheimer’s care, for example, will grow from $1.33 trillion in 2020 to $9.12 trillion in 2050 — comparable or greater than the costs of diseases like lung disease or diabetes that affect more people.

    Effective treatments for Alzheimer’s have proven elusive. Most approved drugs can help manage symptoms but fail to stop or reverse the disease.

    One possible explanation for why drugs haven’t worked so far is they were started too late, when the Alzheimer’s proteins that build up in and around nerve cells have already done too much damage.

    “Drugs can’t resurrect a dying brain,” Hariri said.

    But in the future, the new tool could make it possible to identify people who may be on the way to Alzheimer’s sooner, and evaluate interventions to stop it — before brain damage becomes extensive, and without waiting decades for follow-up.

    In addition to predicting our risk of dementia over time, the new clock will also help scientists better understand why people with certain risk factors, such as poor sleep or mental health conditions, age differently, said first author Ethan Whitman, who is working toward a Ph.D. in clinical psychology with Hariri and study co-authors Terrie Moffitt and Avshalom Caspi, also professors of psychology and neuroscience at Duke.

    More research is needed to advance DunedinPACNI from a research tool to something that has practical applications in healthcare, Whitman added.

    But in the meantime, the team hopes the tool will help researchers with access to brain MRI data measure aging rates in ways that aging clocks based on other biomarkers, such as blood tests, can’t.

    “We really think of it as hopefully being a key new tool in forecasting and predicting risk for diseases, especially Alzheimer’s and related dementias, and also perhaps gaining a better foothold on progression of disease,” Hariri said.

    The authors have filed a patent application for the work. This research was supported by the U.S. National Institute on Aging (R01AG049789, R01AG032282, R01AG073207), the UK Medical Research Council (MR/X021149/1), and the New Zealand Health Research Council (Programme Grant 16-604).

    Source:

    Journal reference:

    Whitman, E. T., et al. (2025). DunedinPACNI estimates the longitudinal Pace of Aging from a single brain image to track health and disease. Nature Aging. doi.org/10.1038/s43587-025-00897-z.

    Continue Reading

  • New cutting-edge software can help uncover hidden features of childhood heart tumors

    New cutting-edge software can help uncover hidden features of childhood heart tumors

    New cutting-edge software developed in Melbourne can help uncover how the most common heart tumor in children forms and changes. And the technology has the potential to further our understanding of other childhood diseases, according to a new study.

    The research, led by Murdoch Children’s Research Institute (MCRI) and published in Genome Biology, found the software, VR-Omics, can identify previously undetected cell activities of cardiac rhabdomyoma, a type of benign heart tumor.

    Developed by MCRI’s Professor Mirana Ramialison, VR-Omics is the first tool capable of analysing and visualising data in both 2D and 3D virtual reality environments. The innovative technology aims to analyse the spatial genetic makeup of human tissue to better understand a specific disease.

    Cardiac rhabdomyoma, usually detected during pregnancy or infancy, doesn’t cause health problems in most cases. But in some babies and children the tumors can grow and block blood flow to vital organs, causing respiratory distress, irregular heartbeat, obstructions and heart failure.

    When the tumors cause severe health complications, treatment options are limited and include surgically removing part of the heart, which may lead to further complications and death. Unfortunately, it’s not well understood why these tumors form.”


    Professor Mirana Ramialison, MCRI

    To challenge her new software, Professor Ramialison and her team, including Denis Bienroth and Natalie Charitakis, analysed heart tissue from three children in Melbourne with cardiac rhabdomyoma. In a breakthrough, the research uncovered specific underlying features of the tumor that hadn’t been identified previously.

    Professor Ramialison said the VR-Omics tool would help researchers to gain a better insight into the disease.

    “VR-Omics generates 3D visualisations of the cells within human tissue based on large collections of patient data,” she said. This could allow for greater analysis of human tissue compared to other methods.”

    Professor Ramialison also benchmarked the software against existing state-of-the-art methods, finding it performed better in all analysis steps.

    “VR-Omics has a unique capacity to analyze large datasets, which allows it to explore new biological mechanisms in rare tissue sections, like those from cardiac rhabdomyoma,” she said. The technology will enable more biological discoveries that could help better understand many childhood conditions.”

    Researchers from the Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine (CardioRegen), the University of Konstanz in Germany, Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), University of Melbourne and Monash University also contributed to the findings.

    Source:

    Murdoch Childrens Research Institute

    Journal reference:

    Bienroth, D., et al. (2025). Automated integration of multi-slice spatial transcriptomics data in 2D and 3D using VR-Omics. Genome Biology. doi.org/10.1186/s13059-025-03630-6.

    Continue Reading

  • Friends and social media drive teen vaping trends

    Friends and social media drive teen vaping trends

    Young people with friends who vape are 15 times more likely to use e-cigarettes, and more adolescents are turning to illicit cannabis products, University of Queensland research has found.

    In two separate UQ-led studies, researchers have uncovered vaping trends, including a significant increase in the number of young people who don’t know what they’re inhaling.

    In one study, PhD candidate Jack Chung from UQ’s National Centre For Youth Substance Use Research examined the types of cannabis compounds that youth aged 11-18 years old were vaping between 2021 and 2023.

    We analyzed how many teens were vaping 2 types of cannabis compounds, the first of which is commonly used for its psychoactive ‘high’ effects, and the 2nd is usually used for medicinal purposes.


    We also studied the use of lab-made synthetic cannabinoids which can be more potent and deadly.


    We saw an increase in all products between 2021 and 2023, but it was concerning to see a rise in synthetic cannabinoids, where vaping doubled in young people aged between 11-15 years.


    Synthetic cannabinoids are particularly dangerous as they can lead to unpredictable health consequences and even death.


    It was also worrying to see more adolescents were unsure about the substances they were vaping – 1.8 per cent of teens in 2021 weren’t sure if they had vaped synthetic cannabinoids, increasing to 4.7 per cent in 2023.”


    Jack Chung, PhD candidate from UQ’s National Centre For Youth Substance Use Research

    Mr. Chung’s study analyzed data from 70,773 middle and high school students in the United States, which was captured in the country’s National Youth Tobacco Surveys.

    In a separate UQ-led vaping study, PhD candidate Giang Vu found peer influences were a major factor in vaping trends, while disapproval of e-cigarettes from people important to teens – such as parents – reduced the likelihood of a teen vaping by about 70 per cent.

    “We analyzed data from 20,800 American youth between 2015 and 2021 and found while the proportion with friends who smoked declined, having friends who vaped remained concerningly common,” Ms Vu said.

    “In 2015, 31.6 per cent of young people had friends who vaped, and while this decreased to 22.3 per cent by 2021, this figure is still high.

    “The outbreak of lung disease associated with vaping, and COVID-19 related disruptions to social networks and access most likely contributed to this decline.”

    Associate Professor Gary Chung Kai Chan, who collaborated on both studies, said social media played a big part in vaping rates among young people.

    “In many videos, vaping is portrayed as trendy and a healthier lifestyle choice when compared to cigarette smoking, but this is dangerous messaging,” Dr Chan said.

    “We need more regulation on social media, along with targeted policies and campaigns to decrease vaping rates.

    “Further research is also needed to help us understand the evolving trends of cannabis vaping and the physical and mental health impacts on youth.”

    The first paper has been published in American Journal of Preventative Medicine.

    The second paper has been published in Nicotine & Tobacco Research.

    Key findings:

    Adolescent cannabis vaping trends:

    • In 2023, it was estimated:

      • 7.4 per cent of US adolescents were vaping a cannabinoid known as THC (which is extracted from the cannabis plant and produces a psychoactive high)
      • 2.9 per cent were vaping cannabidiol known as CBD (also extracted from a cannabis plant and is more often used for medicinal purposes)
      • 1.8 per cent were vaping synthetic cannabinoids (a dangerous lab-made drug that mimics the effects of cannabis)


    • Vaping of all 3 products increased between 2021 and 2023 in teenagers aged 11-18 years old.
    • Vaping rates were higher among females than males.
    • The number of 11-13-year-olds vaping THC and synthetic cannabinoids doubled between 2021 and 2023.
    • Consistent increase in the number of teens who weren’t sure what product they had inhaled.

    Trends in social norms towards cigarette smoking and e-cigarette use:

    • Teens who had friends who vaped were 15 times more likely to use e-cigarettes themselves.
    • Between 2015 and 2021, the probability of having friends who smoked cigarettes decreased from 26.1 per cent to 7.9 per cent.
    • Meanwhile, the probability of having friends who vaped decreased from 31.6 per cent to 22.3 per cent.
    • Between 2015 and 2020, perceived public disapproval increased for both cigarettes (73.3 per cent to 84.2 per cent) and vaping (55.4 per cent to 77.5 per cent).
    • Disapproval of e-cigarettes from people important to teens reduced the likelihood of a teen vaping by about 70 per cent.

    Source:

    The University of Queensland

    Journal references:

    1. Chung, J., et al. (2025). Adolescent Cannabis Vaping Trends (2021–2023): Delta-9-Tetrahydrocannabinol, Cannabidiol, and Synthetic Cannabinoids. American Journal of Preventive Medicine. doi.org/10.1016/j.amepre.2025.107655.
    2. Vu, G. T., et al. (2025) Trends in Social Norms Toward Cigarette Smoking and E-cigarette Use Among U.S. Youth Between 2015 and 2021. Nicotine & Tobacco Research. doi.org/10.1093/ntr/ntaf120.

    Continue Reading

  • Comprehensive support key to smoking cessation success for smokers leaving rehab: study-Xinhua

    CANBERRA, July 2 (Xinhua) — Offering various nicotine replacements or vapes with behavioral support helps people leaving rehab stay smoke-free, a group where long-term quitting is rare, a new clinical trial has found.

    The study, which tracked over 360 adults exiting detox programs, added to growing evidence that, with consistent support and a variety of nicotine replacement options, people in recovery can achieve meaningful progress in quitting smoking, according to a release on Tuesday from Flinders University in South Australia which led the study.

    This potentially saves lives and reduces the heavy health burden associated with tobacco use in this vulnerable population, according to the study published in the July issue of the Lancet Public Health.

    “People recovering from substance use are more than twice as likely to smoke as the general population — and far more likely to suffer and die from tobacco-related illness,” said the study’s lead author Billie Bonevski, director of the Flinders Health and Medical Research Institute.

    Participants were randomly assigned either a 12-week supply of vapes or a combination of nicotine replacement therapy products such as patches, gum, lozenges, inhalators, and mouth sprays. Both groups also received behavioral counseling through Quitline services, the researchers said.

    After nine months, 10 percent of participants in both groups remained smoke-free, a notable achievement in a population with high smoking rates and typically low quit success, the study showed.

    “This isn’t about one therapy outperforming another — it’s about building a system that gives people the best chance to succeed,” Bonevski said, adding ongoing support and access to multiple quit tools matter more than the type of nicotine therapy, calling for smoking cessation to be fully integrated into addiction treatment.

    Continue Reading

  • Blood Test May Flag Early Heart Transplant Rejection

    Blood Test May Flag Early Heart Transplant Rejection

    Photo Credit: iStock.com/KS Kim

    Research shows that small extracellular vesicles shed by donor heart cells and circulating T cells provide a precise readout of heart transplant rejection.


    Although routine endomyocardial biopsy remains the gold standard for grading acute cellular rejection (ACR) after heart transplantation, new research published in Transplantation has shown that small extracellular vesicles (sEVs) shed by donor heart cells and circulating T cells provide a precise, minimally invasive readout of rejection.

    “T cells are constantly surveilling their environment, looking for infections and other things that are ‘non-self,’” explained study principal investigator Prashanth Vallabhajosyula, MD, MPH, of Yale School of Medicine, in a news release. “They see the transplanted heart as non-self, so they mount an attack.”

    Distinct Molecular Shifts Signal Danger

    In a longitudinal pilot study, the researchers collected 70 paired blood samples and biopsies from 12 recipients during the first 120 postoperative days. They isolated donor-derived sEVs with anti-human leukocyte antigens (HLA) I beads and probed for cardiac troponin T (cTnT) protein and messenger ribonucleic acid (mRNA), while anti-cluster of differentiation 3 beads captured T-cell sEVs enriched for cluster of differentiation 4, cluster of differentiation 8, T-cell receptor proteins, and microRNAs (mRNAs) let-7i, 101b, and 21a.

    According to study results, eleven episodes of moderate ACR occurred in six patients (incidence 15.7%). Compared with grade 0/1 biopsies, donor-heart sEV cTnT protein and mRNA fell markedly (P<0.001), whereas T-cell sEV protein and miRNA cargoes rose (all P<0.001). These shifts were detectable as early as day 5 post-transplant; ten of the eleven episodes presented within 38 days, a timeframe in which commercial blood tests typically fail, according to the authors.

    Monitoring Treatment Success

    By escalating immunosuppression, the researchers reversed both clinical rejection and sEV signatures. Donor-heart cTnT mRNA and miR-21a tracked treatment response with Spearman coefficients of 0.87 and 0.85, respectively.

    “Not only can we detect rejection, but our investigation also suggests that we can use our exosome platform to potentially monitor the efficacy of treatment of rejection,” Vallabhajosyula stated. The authors noted that the platform also identified one case of antibody-mediated rejection by analyzing B-cell sEVs, highlighting its versatility.

    Toward Safer Transplant Care

    “This is the first time that we’ve had a noninvasive method to delineate between the different types of rejection that may occur within the heart,” noted study co-author Sounok Sen, MD, of Yale School of Medicine.

    According to the researchers, a larger validation study involving more than 100 patients is underway to refine diagnostic thresholds and assess long-term prognostic value. They noted that, if confirmed, sEV profiling could significantly reduce the need for repeat biopsies, lower procedural complications, and enable clinicians to adjust therapy earlier, ultimately improving outcomes for heart transplant recipients.

    Continue Reading

  • Association Between Dietary Habits and Depressive Symptoms in University Students: A Cross-Sectional Study Using the Japanese Version of the Quick Inventory of Depressive Symptomatology (QIDS-J)

    Association Between Dietary Habits and Depressive Symptoms in University Students: A Cross-Sectional Study Using the Japanese Version of the Quick Inventory of Depressive Symptomatology (QIDS-J)


    Continue Reading

  • Epidemiological Update – Measles in the Americas Region – 1 July 2025 – PAHO/WHO

    In 2025, between epidemiological week (EW) 1 and EW 24, in the Americas Region, 7,132 measles cases have been confirmed, including 13 deaths, in Argentina (n= 34), Belize (n= 34), the Plurinational State of Bolivia (n= 60), Brazil (n= 5), Canada (n= 3,170, including one death),2 Costa Rica (n= 1 case), Mexico (n= 2,597 cases, including nine deaths), Peru (n= 4 cases), and the United States of America (n= 1,227, including three deaths).

    According to the information available from confirmed cases, the age group with the highest proportion of cases corresponds to the 10-19 years old group (24%), the 1-4 year old group (22%), and the 20-29 year old group (19%).

    Continue Reading

  • Zapping Volunteers’ Brains With Electricity Boosted Their Maths Skills : ScienceAlert

    Zapping Volunteers’ Brains With Electricity Boosted Their Maths Skills : ScienceAlert

    Struggle with math? A gentle jolt to the brain might help.

    A new study published Tuesday in PLOS Biology suggests that mild electrical stimulation can boost arithmetic performance – and offers fresh insight into the brain mechanisms behind mathematical ability, along with a potential way to optimize learning.

    The findings could eventually help narrow cognitive gaps and help build a more intellectually equitable society, the authors argue.

    “Different people have different brains, and their brains control a lot in their life,” said Roi Cohen Kadosh, a neuroscientist at the University of Surrey who led the research.

    “We think about the environment – if you go to the right school, if you have the right teacher – but it’s also our biology.”

    Cohen Kadosh and colleagues recruited 72 University of Oxford students, scanning their brains to measure connectivity between three key regions.

    Related: Chewing Wood Could Give Your Brain an Unexpected Boost

    Participants then tackled math problems that required either calculating answers or recalling memorized solutions.

    Participants calculated mathematical problems while having their brains scanned. (pixelshot/Canva)

    They found that stronger connections between the dorsolateral prefrontal cortex, which governs executive function, and the posterior parietal cortex, involved in memory, predicted better calculation performance.

    When the researchers applied a painless form of brain stimulation using electrode-fitted caps – a technique known as transcranial random noise stimulation – the low performers saw their scores jump by 25–29 percent.

    The team believes the stimulation works by enhancing the excitability of neurons and interacting with GABA, a brain chemical that inhibits excessive activity – effectively compensating for weak neural connectivity in some participants.

    In fact, the stimulation helped underperformers reach or even surpass the scores of peers with naturally stronger brain wiring. But those who already performed well saw no benefit.

    “Some people struggle with things, and if we can help their brain to fulfill their potential, we open them a lot of opportunities that otherwise would be closed,” said Cohen Kadosh, calling it an “exciting time” for the field of brain stimulation research.

    Still, he flagged a key ethical concern: the risk that such technologies could become more available to those with financial means, widening – rather than closing – access gaps.

    He also urged the public not to try this at home. “Some people struggle with learning, and if our research proves successful beyond the lab, we could help them fulfil their ambitions and unlock opportunities that might otherwise remain out of reach.”

    © Agence France-Presse

    Continue Reading

  • Nurse holding up hands of ‘untouchables’ for decades

    Nurse holding up hands of ‘untouchables’ for decades

    Xing Shaoyun

    The first time Xing Shaoyun reached for a leprosy patient”s disfigured hand, the patient flinched. “Don’t touch me,” she whispered. “I don’t want to make you sick.”

    That moment shattered Xing’s last barrier of fear and redefined her life’s mission.

    Now 49, the head nurse of Hainan Fifth People’s Hospital, also known as Hainan Skin Disease and Plastic Surgery Hospital, has spent three decades eradicating the stigma with radical compassion, earning her China’s highest medical honor, the Norman Bethune Award, on March 31.

    “They weren’t afraid of us, but they were afraid for us,” Xing recalled. “That’s when I understood: dignity hurts worse than disease.”

    When Xing graduated from a health vocational college in 1995 and began working at Hainan’s largest leprosy colony, isolation was the norm. Patients, many with untreated ulcers, lived behind walls and were abandoned by families. Medical staff wore hazmat-like gear.

    Despite her family’s fears about the risks of her work, Xing changed that calculus with science. She adopted masking, gloving and sterilizing protocols so rigorous that direct contact became safe. Then she added what medicine couldn’t measure — sitting for hours listening to life stories and holding hands gnarled by nerve damage.

    “Leprosy steals everything — jobs, marriages, even hugs,” said Xing, scrolling through photos of elderly patients on her phone. One image shows a man grinning as she fits him with custom shoes; another, a woman smiling while Xing dresses her wounds. “What they need most isn’t just treatment. It’s being seen.”

    Her clinical breakthroughs are textbook cases: By combining regenerative wound tech with photon therapy, her team slashed chronic ulcer rates from 28 percent to 5 percent, significantly lowering amputation risks. The innovation now guides leprosy hospitals nationwide.

    Beyond the clinic, Xing ventured into remote regions to conduct hands-on training. In 2019, she led a province-wide survey across 13 leprosy-affected villages, finding ulcer incidence rates as high as 18.9 percent. In response, she launched a mobile treatment campaign and trained 464 local caregivers, building a grassroots network of leprosy care specialists.

    Yet her most fragile patients never leave the geriatric ward. Xing helped establish a tailored geriatric care system that treats both physical disabilities and social stigma.

    “Some patients hadn’t held anyone’s hand in decades,” she said. “We’ve held over 100 hands in their last moments. No one should die remembering only pain.”

    In 2023, Xing was awarded the Florence Nightingale Medal by the International Red Cross. She has since shared her experience with nearly 4,000 people through lectures, inspiring a new generation of health workers.

    Xing has taken care of over 300 leprosy patients. “The elderly patients often call me ‘daughter’, a sign of their trust and the reason I keep going,” said Xing.

    With China’s leprosy rates plummeting, she believes key challenges remain in early detection, especially in remote areas, and in comprehensive rehabilitation addressing both physical and psychological needs.

    As a Party member for 23 years, Xing views her awards as a recognition of teamwork, not individual achievement. “My oath to serve the people guides everything — ward rounds, emergencies, trips to remote villages,” she said. “These honors are not just for me but they belong to thousands of front-line medical workers and leprosy control staff.”

    Continue Reading

  • 14th polio case of this year emerges

    14th polio case of this year emerges





    14th polio case of this year emerges – Daily Times

































    Continue Reading